Marcus Zervos

586 total citations
27 papers, 255 citations indexed

About

Marcus Zervos is a scholar working on Epidemiology, Infectious Diseases and Psychiatry and Mental health. According to data from OpenAlex, Marcus Zervos has authored 27 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Psychiatry and Mental health. Recurrent topics in Marcus Zervos's work include Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers), Pneumonia and Respiratory Infections (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Marcus Zervos is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers), Pneumonia and Respiratory Infections (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Marcus Zervos collaborates with scholars based in United States, Jordan and Argentina. Marcus Zervos's co-authors include Anita Shallal, Madonna Matar, Howard J. Dworkin, Michael G. Rinaldi, James T. Fitzgerald, Deanna A. Sutton, Stephen Sanche, Sanjay G. Revankar, Rachel M. Kenney and Manu Malhotra and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Frontiers in Microbiology.

In The Last Decade

Marcus Zervos

21 papers receiving 238 citations

Peers

Marcus Zervos
Linda Mann United States
Marcus Zervos
Citations per year, relative to Marcus Zervos Marcus Zervos (= 1×) peers Linda Mann

Countries citing papers authored by Marcus Zervos

Since Specialization
Citations

This map shows the geographic impact of Marcus Zervos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Zervos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Zervos more than expected).

Fields of papers citing papers by Marcus Zervos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Zervos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Zervos. The network helps show where Marcus Zervos may publish in the future.

Co-authorship network of co-authors of Marcus Zervos

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Zervos. A scholar is included among the top collaborators of Marcus Zervos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Zervos. Marcus Zervos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suleyman, Geehan, Jagjeet Kaur, Gina Maki, et al.. (2025). Genomic Analysis and Virulence Features of Vibrio cholerae Non‐ O1 /Non‐ O139 Harbouring CARB ‐Type β‐Lactamases From Freshwater Bodies, Argentina. Environmental Microbiology Reports. 17(5). e70181–e70181.
2.
Tibbetts, Robert, Audun Sivertsen, Alemu Fite, et al.. (2025). New diagnostic methods for Escherichia marmotae and the first report of its identification in clinical isolates in North America. Frontiers in Microbiology. 16. 1664775–1664775. 1 indexed citations
4.
Dinh, An Q, Blake Hanson, German Contreras, et al.. (2022). 128. Association of PBP4 Variants and β-lactam Susceptibility in Enterococcus faecalis. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations
5.
Shallal, Anita, Evi Abada, Hyejeong Jang, et al.. (2021). Human Papillomavirus Infection and Cervical Dysplasia in a Subset of Arab American Women. Women s Health Reports. 2(1). 273–278. 2 indexed citations
6.
Shallal, Anita, et al.. (2021). Vancomycin-Resistant Enterococci. Infectious Disease Clinics of North America. 35(4). 953–968. 36 indexed citations
7.
Kenney, Rachel M., et al.. (2019). Discharge Delays and Costs Associated With Outpatient Parenteral Antimicrobial Therapy for High-Priced Antibiotics. Clinical Infectious Diseases. 71(7). e88–e93. 18 indexed citations
8.
Alviano, Daniela Sales, et al.. (2018). Comparison of Mortality and Therapy in Community Acquired Pneumonia. ThinkIR: The University of Louisville's Institutional Repository (University of Louisville). 2(2). 19–21.
9.
Bardossy, Ana Cecilia, Karen Jones, Susan Szpunar, et al.. (2018). Culturing practices and the care of the urinary catheter in reducing NHSN-defined catheter-associated urinary tract infections: The tale of two teaching hospitals. Infection Control and Hospital Epidemiology. 39(12). 1494–1496. 5 indexed citations
10.
Alviano, Daniela Sales, et al.. (2018). Comparison of Mortality and Therapy in Community Acquired Pneumonia. 2(2). 19–21.
11.
Fakih, Mohamad G., Karen Jones, Ana C. Bardossy, et al.. (2015). Improving the Culture of Culturing: When Do Resident Physicians Obtain Urine Cultures, and What Do They Do With Them?. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations
12.
Yuan, Xin, Daniela Sales Alviano, Anthony D. Harris, et al.. (2015). Risk Factors Associated With 30-Day Readmission in Patients With Healthcare-Associated Pneumonia. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations
13.
Yuan, Xin, Daniela Sales Alviano, Anthony D. Harris, et al.. (2015). Risk Factors Associated With 30-Day Readmission in Patients With Community-Acquired Pneumonia. Open Forum Infectious Diseases. 2(suppl_1).
14.
Zervos, Marcus, et al.. (2014). Hospital roommates and development of health care–onset Clostridium difficile infection. American Journal of Infection Control. 42(10). 1109–1111. 8 indexed citations
15.
Baxa, Dwayne, et al.. (2011). In vitro evaluation of a novel process for reducing bacterial contamination of environmental surfaces. American Journal of Infection Control. 39(6). 483–487. 20 indexed citations
16.
Beqaj, Safedin, Robert G Deeter, Howard J. Dworkin, et al.. (2002). A six-month trial of valacyclovir in the Epstein-Barr virus subsetof chronic fatigue syndrome: Improvement in left ventricularfunction. Drugs of today. 38(8). 549–549. 14 indexed citations
17.
Revankar, Sanjay G., et al.. (1999). Metarrhizium anisopliae as a Cause of Sinusitis in Immunocompetent Hosts. Journal of Clinical Microbiology. 37(1). 195–198. 27 indexed citations
18.
Lerner, A. Martin, Marcus Zervos, Howard J. Dworkin, et al.. (1997). NEW CARDIOMYOPATHY. Infectious Diseases in Clinical Practice. 6(2). 110–117. 12 indexed citations
19.
Lerner, A. Martin, et al.. (1997). A UNIFIED THEORY OF THE CAUSE OF CHRONIC FATIGUE SYNDROME. Infectious Diseases in Clinical Practice. 6(4). 239–242. 9 indexed citations
20.
Zervos, Marcus, et al.. (1994). The Clinical Laboratory’s Role in Hospital Infection Control. Laboratory Medicine. 25(10). 642–647. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026